Amwell (NYSE: AMWL) reported Q2 EPS of ($0.15), $0.04 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $60.2 million versus the consensus estimate of $61.7 million.

GUIDANCE:

Amwell sees FY2021 revenue of $252-262 million, versus the consensus of $263 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.